Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study
PLOS ONE · 31.03.2025 · 20 (3) · e0316052
DOI: 10.1371/journal.pone.0316052 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, online erschienen am 31.03.2025. Verfasst von Diego Santos-García und 8 weiteren Autor:innen. Beteiligte Einrichtung: CHUAC, Complejo Hospitalario Universitario de A. Coruña, A. Coruña, Spain. Hauptthemen laut MEDLINE: Antiparkinson Agents, Levodopa, Parkinson Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objective Device-aided therapies (DATs) are treatments indicated for people with Parkinson´s disease (PwP) experiencing clinical fluctuations that remain suboptimal despite conventional medication. New DATs have recently emerged such as levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) and subcutaneous infusion of foslevodopa/foscarbidopa (fLD/fCD). Understanding the differences between various DATs is essential. Patients and Methods We present here the protocol study of the DATs-PD GETM Spanish Registry. This is a descriptive, observational, prospective, multicenter, open study that is proposed as a clinical registry with progressive inclusion of PwP treated with a DAT in daily clinical practice conditions in more 40 centers from Spain for 10 years. The principal aim is to know the type of DAT that PwP in our country (Spain) receive. Specific objectives are to compare the clinical characteristics of the patients, the effectiveness, safety and tolerability, to identify predictors of a good response and to analyze the response by groups (gender, disease duration, phenotype, etc.). There is a baseline visit (V1; indication of the therapy), start visit (V2; initiation of the therapy) and follow-up visits at 6 months ± 3 months (V3_6M) and after this annually ± 3 months for 10 years (V3_12M, V3_24M, etc.).
Results
The registry is on going. The first patient was included on April 10, 2024. Patient recruitment and follow-up will be conducted until 31/DEC/2033. It is estimated that the registry will include a minimum of 3,000 patients.
Conclusion
The present study will help improve the care of PD patients treated with a DAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CHUAC, Complejo Hospitalario Universitario de A. Coruña, A. Coruña, Spain.
- Grupo de Investigación en Enfermedad de Parkinson y otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), A Coruña, Spain.
- Hospital San Rafael, A. Coruña, Spain.
- Fundación Degen, A. Coruña, Spain.
- Hospital Universitario de Móstoles, Madrid, Spain.
- Hospital Universitario Puerta de Hierro, Madrid, Spain.
ORCID-Profile: Diego Santos-García, Anna Planas-Ballvé
Zitieren
APA
Santos-García, D., González-Ortega, G., Sánchez-Alonso, P., Planas-Ballvé, A., García-Ramos, R., Cabo, I., Blázquez-Estrada, M., Sánchez-Ferro, Á., & DATs-P. D. GETM Spanish Registry Group (2025). Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study. PLOS ONE, 20(3), e0316052. https://doi.org/10.1371/journal.pone.0316052
Vancouver
Santos-García D, González-Ortega G, Sánchez-Alonso P, Planas-Ballvé A, García-Ramos R, Cabo I, et al. Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study. PLOS ONE. 2025;20(3):e0316052. doi:10.1371/journal.pone.0316052
BibTeX
@article{SantosGarca2025,
author = {Santos-García, Diego and González-Ortega, Guillermo and Sánchez-Alonso, Pilar and Planas-Ballvé, Anna and García-Ramos, Rocío and Cabo, Iria and Blázquez-Estrada, Marta and Sánchez-Ferro, Álvaro and DATs-P. D. GETM Spanish Registry Group, DATs-P. D. GETM Spanish Registry Group},
title = {Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {3},
pages = {e0316052},
doi = {10.1371/journal.pone.0316052}
}
EUVIMED